Besides PD-L1 expression levels on T cells and tumor cells, Liu et al. 10 found that high-level of PD-L1 expression on CD68+ macrophages correlated with longer OS in NSCLC patients treated with immunotherapy. The gene discussed is CD274; the disease is neoplasm.